🇺🇸 FDA
Patent

US 6551588

Tumor radiosensitization using gene therapy

expired A61KA61K38/193A61K38/202

Quick answer

US patent 6551588 (Tumor radiosensitization using gene therapy) held by The Regents of the University of California expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/193, A61K38/202, A61K39/0011, A61K48/00